Analysed ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) News Sources
Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates
12-03-2026
yahoo.com
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
12-03-2026
yahoo.com
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
03-03-2026
yahoo.com
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13-02-2026
yahoo.com
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest shareholders are retail investors with 41% ownership, institutions own 17%
22-01-2026
yahoo.com
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
12-01-2026
yahoo.com
TD Cowen Initiates Orchestra BioMed (OBIO), Cites High-Margin Potential in Lead Cardiovascular Programs
31-12-2025
yahoo.com
What is the current price of ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ)?
The current price of ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) is $4.33.
ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) since the previous trading day is $0.2.
ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) since the previous trading day is 4.8426%.
What is the most recent average sentiment score for ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ)?
The most recent average sentiment score for ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ)?
The most recent sentiment for ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) is .
SEC-8K** Filing Available For ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.